Annual Current Liabilities:
$106.92M+$57.02M(+114.28%)Summary
- As of today, NAMS annual current liabilities is $106.92 million, with the most recent change of +$57.02 million (+114.28%) on December 31, 2024.
- During the last 3 years, NAMS annual current liabilities has risen by +$95.73 million (+855.79%).
- NAMS annual current liabilities is now at all-time high.
Performance
NAMS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Current Liabilities:
$36.51M-$4.40M(-10.76%)Summary
- As of today, NAMS quarterly current liabilities is $36.51 million, with the most recent change of -$4.40 million (-10.76%) on June 30, 2025.
- Over the past year, NAMS quarterly current liabilities has dropped by -$8.79 million (-19.41%).
- NAMS quarterly current liabilities is now -65.85% below its all-time high of $106.92 million, reached on December 31, 2024.
Performance
NAMS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NAMS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +114.3% | -19.4% |
| 3Y3 Years | +855.8% | +1890.2% |
| 5Y5 Years | +578.7% | +10000.0% |
NAMS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +855.8% | -65.8% | +858.9% |
| 5Y | 5-Year | at high | +855.8% | -65.8% | >+9999.0% |
| All-Time | All-Time | at high | +855.8% | -65.8% | >+9999.0% |
NAMS Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $36.51M(-10.8%) |
| Mar 2025 | - | $40.91M(-61.7%) |
| Dec 2024 | $106.92M(+114.3%) | $106.92M(+159.2%) |
| Sep 2024 | - | $41.26M(-8.9%) |
| Jun 2024 | - | $45.31M(-24.1%) |
| Mar 2024 | - | $59.73M(+1468.5%) |
| Dec 2023 | $49.90M(+38.4%) | - |
| Dec 2022 | $36.06M | - |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $3.81M(+107.6%) |
| Jun 2022 | - | $1.83M(+1605.0%) |
| Mar 2022 | - | $107.60K(-51.6%) |
| Dec 2021 | $11.19M(-29.0%) | $222.10K(-9.7%) |
| Sep 2021 | - | $245.90K(+109.3%) |
| Jun 2021 | - | $117.50K(-51.7%) |
| Mar 2021 | - | $243.30K(+2.9%) |
| Dec 2020 | $15.75M | $236.50K |
FAQ
- What is NewAmsterdam Pharma Company N.V. annual current liabilities?
- What is the all-time high annual current liabilities for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. annual current liabilities year-on-year change?
- What is NewAmsterdam Pharma Company N.V. quarterly current liabilities?
- What is the all-time high quarterly current liabilities for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. quarterly current liabilities year-on-year change?
What is NewAmsterdam Pharma Company N.V. annual current liabilities?
The current annual current liabilities of NAMS is $106.92M
What is the all-time high annual current liabilities for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high annual current liabilities is $106.92M
What is NewAmsterdam Pharma Company N.V. annual current liabilities year-on-year change?
Over the past year, NAMS annual current liabilities has changed by +$57.02M (+114.28%)
What is NewAmsterdam Pharma Company N.V. quarterly current liabilities?
The current quarterly current liabilities of NAMS is $36.51M
What is the all-time high quarterly current liabilities for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high quarterly current liabilities is $106.92M
What is NewAmsterdam Pharma Company N.V. quarterly current liabilities year-on-year change?
Over the past year, NAMS quarterly current liabilities has changed by -$8.79M (-19.41%)